Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 7 Prostatic Neoplasms 2 Lung Neoplasms 2 Urinary Bladder Neoplasms 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 Multiple Myeloma 1 Leukemia, Myeloid, Acute 1 Gastroesophageal Adenocarcinoma 1 Carcinoma, Renal Cell 1 Carcinoma 1

Interventions

Gemcitabine 677 130-nm albumin-bound paclitaxel 197 Fluorouracil 184 Oxaliplatin 173 Albumin-Bound Paclitaxel 151 Capecitabine 137 Leucovorin 129 Irinotecan 111 Radiotherapy 95 Taxes 83 pembrolizumab 80 Cisplatin 71 Erlotinib Hydrochloride 69 Radiosurgery 67 Nivolumab 56 Bevacizumab 54 Drug Therapy 52 Cyclophosphamide 48 Magnetic Resonance Spectroscopy 45 folfirinox 42 Docetaxel 41 Cetuximab 40 irinotecan sucrosofate 36 Specimen Handling 36 S 1 (combination) 36 Biopsy 30 Radiation 29 Paclitaxel 29 Ipilimumab 27 Surgical Procedures, Operative 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Pancreatic Neoplasms × Single Person × Clear all

NCT06030622 2024-04-19

C3

State University of New York - Downstate Medical Center

Phase 1/2 Unknown

Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡